ORCID
- Stephen Mullin: 0000-0002-1936-394X
Abstract
Background Variants in the GBA1 gene cause the lysosomal storage disorder Gaucher disease (GD). They are also risk factors for Parkinson's disease (PD), and modify the expression of the PD phenotype. The penetrance of GBA1 variants in PD is incomplete, and the ability to determine who among GBA1 variant carriers are at higher risk of developing PD, would represent an advantage for prognostic and trial design purposes. Objectives To compare the motor and non-motor phenotype of GBA1 carriers and non-carriers. Methods We present the cross-sectional results of the baseline assessment from the RAPSODI study, an online assessment tool for PD patients and GBA1 variant carriers. The assessment includes clinically validated questionnaires, a tap-test, the University of Pennsyllvania Smell Identification Test and cognitive tests. Additional, homogeneous data from the PREDICT-PD cohort were included. Results A total of 379 participants completed all parts of the RAPSODI assessment (89 GBA1-negative controls, 169 GBA1-negative PD, 47 GBA1-positive PD, 47 non-affected GBA1 carriers, 27 GD). Eighty-six participants were recruited through PREDICT-PD (43 non-affected GBA1 carriers and 43 GBA1-negative controls). GBA1-positive PD patients showed worse performance in visual cognitive tasks and olfaction compared to GBA1-negative PD patients. No differences were detected between non-affected GBA1 carriers carriers and GBA1-negative controls. No phenotypic differences were observed between any of the non-PD groups. Conclusions Our results support previous evidence that GBA1-positive PD has a specific phenotype with more severe non-motor symptoms. However, we did not reproduce previous findings of more frequent prodromal PD signs in non-affected GBA1 carriers.
DOI Link
DOI
10.1016/j.nbd.2023.106343
Publication Date
2023-01-01
Publication Title
Neurobiology of Disease
Volume
188
ISSN
0969-9961
Embargo Period
2023-12-06
Recommended Citation
Schapira, A., Toffoli, M., Chohan, H., Mullin, S., Jesuthasan, A., Yalkic, S., Koletsi, S., Menozzi, E., Rahall, S., Limbachiya, N., Loefflad, N., Higgins, A., Bestwick, J., Lucas-Del-Pozo, S., Fierli, F., Farbos, A., Mezabrovschi, R., Lee-Yin, C., Schrag, A., Moreno-Martinez, D., Hughes, D., Noyce, A., Colclough, K., Jeffries, A., & Proukakis, C. (2023) 'Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study', Neurobiology of Disease, 188. Available at: 10.1016/j.nbd.2023.106343
